Professor Steve Bain
Professor in Medicine(Diabetes)
Swansea University Medical School
Telephone: (01792) 602205

Professor Steve Bain is Assistant Medical Director for Research & Development for ABM University Health Board and Clinical Lead for the Diabetes Research Network, Wales.
After undergraduate training at St John's College, Cambridge, he was clinically trained at King's College Hospital, London. Qualifying in 1983, he held junior appointments in London, East Midlands, and West Midlands. His research centred on the genetics of type 1 diabetes, and he was granted a Medical Research Council Lecturership. In 1993, he became a Senior Lecturer/Honorary Consultant Physician at Birmingham Heartlands Hospital, with promotion to Reader in Diabetic Medicine in 1998. Professor Bain became a Fellow of the Royal College of Physicians, UK, in 1996 and was appointed to a newly created Chair in Medicine (Diabetes) at Swansea University in 2005. His clinical interests include the genetics of diabetic nephropathy, new therapies for diabetes and the provision of diabetes services within the community. He has been Principal Investigator for several multi-centre trials investigating novel therapies for diabetes.
As a result of his genetics background, Professor Bain became a member of the inaugural West Midlands Multicentre Research Ethics Committee (MREC) and joined the UK Human Genetics Commission. From 2003-2008 he was HGC’s nomination on the National DNA Database Strategy Board and led the HGC report on DNA testing in 2009. In 2007 he was invited to sit on the newly formed National DNA Database Ethics Group, established by the Secretary of State for the Home Department. Professor Bain is Diabetes Lead Clinician for ABM University Health Board, a member of the Wales Diabetes & Endocrine Society (WEDS) executive committee and chairs the Specialist Training Committee for Diabetes & Endocrinology for Wales. He is also on the Board which oversees the ILS Joint Clinical Research Facility, the premier clinical research institute in Wales and is Clinical Director of the Academic Health Science Collaboration for Wales.

Areas of Expertise

  • R&D

Publications

  1. & Effect of liraglutide on cardiovascular outcomes in elderly patients: post hoc analysis of a randomized controlled trial. Annals of Internal Medicine
  2. et. al. Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial. Diabetes, Obesity and Metabolism
  3. & A multicentred, UK, retrospective observational study to assess the effectiveness of insulin glargine 300 units/mL in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA). Diabetic Medicine
  4. & Worsening diabetic retinopathy with rapid improvement in systemic glucose control: a review. Diabetes, Obesity and Metabolism
  5. & Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. Diabetes Care 41(9), 1938-1946.

See more...

Teaching

  • PMDM05 Diabetes Management II

    This core module is delivered primarily as a 5-day residential that aims to enhance the students¿ knowledge of the advanced treatments for diabetes. It will explore continuous/flash glucose monitoring and all aspects of pump technologies and pregnancy usage. This will enable the students to see and handle these new technologies that are not necessarily common place in clinics, and appreciate the concept of treatment planning and progression using these devices. The module will be delivered primarily on campus (5-day residential) with extra online content, and both in situ and online assessments.

  • PMDM101 Diabetic Practice

Supervision

  • Interstitial glucose monitoring around sustained moderate intensity exercse in individuals with type 1 diabetes (current)

    Student name:
    MSc
    Other supervisor: Dr Richard Bracken
  • Provisional Title: Influence of aerobic exercise on glycaemic, counter-regulatory, and cardio-vascular variables in type 1 diabetes (current)

    Student name:
    PhD
    Other supervisor: Dr Richard Bracken
  • The use of Proinsulin in identification of glucose intolerance (current)

    Student name:
    PhD
    Other supervisor: Prof Stephen Luzio
  • no change needed (current)

    Student name:
    MD
    Other supervisor: Prof Ronan Lyons
  • 'Temporal Effects of Bariatric Surgery on Cardiovascular Risk, Glucose Metabolism and Inflammation at 5 years Follow-Up' (awarded 2018)

    Student name:
    MD
    Other supervisor: Prof Jeffrey Stephens